Cargando…

Natural History, Recurrence, and Progression in Superficial Bladder Cancer

Superficial bladder cancer encompasses patients with stage Ta T1 tumors and patients with carcinoma in situ (CIS). The natural history or treatment-related prognosis of these patients varies considerably from one patient to the next based on the patients clinical and the tumor's pathological ch...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sylvester, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917231/ https://www.ncbi.nlm.nih.gov/pubmed/17619739 http://dx.doi.org/10.1100/tsw.2006.404

Ejemplares similares

Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
por: Mitrakas, Lampros P., et al.
Publicado: (2015)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
por: Wang, Tian-Wei, et al.
Publicado: (2019)

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
por: Shin, K. Y., et al.
Publicado: (1997)

Superficial Bladder Cancer Therapy
por: Schenkman, Emmanuel, et al.
Publicado: (2004)

Editorial: Superficial Bladder Cancer
por: Kirkali, Ziya
Publicado: (2006)

Best Approach for Low-Risk Superficial Bladder Cancer
por: Solsona, Eduardo
Publicado: (2006)

Vitamin E Reduces Superficial Bladder Cancer Recurrence: A Randomized Controlled Trial
por: Mazdak, Hamid, et al.
Publicado: (2012)

The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer
por: Nieder, Alan M., et al.
Publicado: (2006)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
por: Ord, J J, et al.
Publicado: (2005)

The natural history of secondary muscle-invasive bladder cancer
por: Hidas, Guy, et al.
Publicado: (2013)

Formulation and characterization of EGCG for the treatment of superficial bladder cancer
por: Dettlaff, Katarzyna, et al.
Publicado: (2017)

Publication of a Special Issue: Superficial Bladder Cancer
por: Redhead, Claire
Publicado: (2006)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer.
por: Bui, T. D., et al.
Publicado: (1998)

Urogenital Schistosomiasis—History, Pathogenesis, and Bladder Cancer
por: Santos, Lúcio Lara, et al.
Publicado: (2021)

Natural history of recurrences in endometrial carcinoma
por: SORBE, BENGT, et al.
Publicado: (2014)

Endoscopic Ultrasonic Aspiration of Superficial Bladder Tumors
por: Miki, Makoto, et al.
Publicado: (1995)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
por: Li, Gang, et al.
Publicado: (2017)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

Natural History of Temporal Lobe Epilepsy: Antecedents and Progression
por: Shukla, Garima, et al.
Publicado: (2012)

Carcinomatous Meningitis: The Natural History of Successfully Treated Metastatic Bladder Cancer
por: Tadepalli, S., et al.
Publicado: (2011)

Natural history of ovarian cancer
por: Vargas, Arturo Novoa
Publicado: (2014)

Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
por: Kamai, T, et al.
Publicado: (2001)

Superficial venous thrombosis: disease progression and evolving treatment approaches
por: Litzendorf, Maria E, et al.
Publicado: (2011)

A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF
por: Hu, Zhiming, et al.
Publicado: (2010)

Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer
por: Saad, Farouk Tijjani, et al.
Publicado: (2017)

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993)

A History of Bladder Stone
por: Librach, I. M.
Publicado: (1971)

The impact of smoking on recurrence and progression of non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Ślusarczyk, Aleksander, et al.
Publicado: (2022)

The Nature of Natural History
Publicado: (1950)

Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression
por: Bordeleau, François, et al.
Publicado: (2023)

An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer
por: Naito, Tomoharu, et al.
Publicado: (2020)

Progress in Personalizing Chemotherapy for Bladder Cancer
por: Chang, James S., et al.
Publicado: (2012)

Natural history and predictors for progression in pediatric keratoconus
por: Antunes-Foschini, Rosalia, et al.
Publicado: (2023)

Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour‐specific immunity
por: Mou, Zezhong, et al.
Publicado: (2023)

A case of eosinophilic cystitis coexisting of superficial bladder cancer, mimicking muscle‐invasive cancer
por: Suhara, Yushi, et al.
Publicado: (2023)

Superficial Urothelial Cancer in the Prostatic Urethra
por: Kirkali, Ziya, et al.
Publicado: (2006)

Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression
por: Crew, J P, et al.
Publicado: (2000)

TGF-BETA IN THE NATURAL HISTORY OF PROSTATE CANCER
por: Ahel, Jamal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2gp1koaeuukghumhcfqss5t1d4